# Excelra

> Excelra supplies curated scientific databases, analytics and research software to pharmaceutical and biotechnology organizations. Its GOSTAR products connect chemical structures with experimental results, while its services cover bioinformatics, data engineering, laboratory informatics and cloud systems.

- **Founded:** 2016
- **Headquarters:** Hyderabad, India
- **Founders:** Anandbir Singh Brar (Founding team member; CEO since 2016)
- **Products:** GOSTAR Small Molecules, GOSTAR TPD, GOSTAR Large Molecules, Custom Biomarker Knowledgebase, BioVisualizer
- **Notable:** Acquired BISC Global in April 2023, adding bioinformatics and analytics platforms and consulting., Announced a third consecutive Great Place to Work certification in March 2024., Expanded GOSTAR Small Molecules into synthesis planning with Retrosynthesis in July 2026.

## Products & services

- **GOSTAR Small Molecules** — Commercial structure-activity relationship database with chemical, biological, pharmacokinetic, safety and patent-derived information; available through an application, APIs and datasets.
- **GOSTAR TPD** — Curated targeted protein degrader data for discovery and compound design.
- **GOSTAR Large Molecules** — Custom curation of large-molecule scientific and patent data.
- **Custom Biomarker Knowledgebase** — Disease-focused biomarker intelligence tailored to a research question.
- **BioVisualizer** — Interactive visualization and statistical exploration of biological data, including RNA-seq.
- **Online Pipeline Platform (OP²)** — Cloud-based sequencing analysis workflows with experiment and file management.
- **Data curation and semantics** — Extracting, standardizing, annotating and integrating chemical, biological and clinical records; ontology mapping and knowledge graphs.
- **Bioinformatics and computational biology** — Omics analysis, target discovery, biomarker research, predictive modeling and patient stratification.
- **Scientific informatics and cloud enablement** — Scientific application development, ELN/LIMS integration, scientific data management and cloud engineering.
- **GOSTAR Retrosynthesis** — AI-assisted route exploration and intermediate availability checks within Small Molecules.

## Achievements

- Acquired BISC Global in April 2023, adding bioinformatics and analytics platforms and consulting.
- Announced a third consecutive Great Place to Work certification in March 2024.
- Expanded GOSTAR Small Molecules into synthesis planning with Retrosynthesis in July 2026.

## Latest updates

- **2026-09** — Excelra published its OpenAI Select Partner announcement on September 15; release dateline August 30.
- **2026-07** — Introduced AI-assisted retrosynthesis inside GOSTAR Small Molecules.
- **2025-12** — Announced more than one million additional SAR data points for GOSTAR Small Molecules.
- **2025-08** — Announced over 10,000 additional degraders for GOSTAR TPD.

## Links

- Website: https://www.excelra.com/
- LinkedIn: https://www.linkedin.com/company/excelra/
- Twitter/X: https://twitter.com/excelra
- YouTube: https://www.youtube.com/@excelra9975
- Facebook: https://facebook.com/excelra

---

Profile page: https://yespress.io/excelra
Published by YesPress — https://yespress.io
Last updated: 2026-10-17